Commentary - (2023) Volume 12, Issue 2
Received: 28-Jan-2023, Manuscript No. pbt-23-94648;
Editor assigned: 30-Jan-2023, Pre QC No. P-94648;
Reviewed: 11-Feb-2023, QC No. Q-94648;
Revised: 17-Feb-2023, Manuscript No. R-94648;
Published:
25-Feb-2023
, DOI: 10.37421/2167-7689.2023.12.355
Citation: Damiati, Safa. “Pharmaceutical Sciences in the Digital
Age.” Pharmaceut Reg Affairs 12 (2023): 355.
Copyright: © 2023 Damiati S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Many fields, including pharmaceutical sciences, have shown a significant interest in artificial intelligence (AI) and machine learning in particular. New machine learning applications in a variety of pharmaceutical sciences have skyrocketed as a result of the explosive growth of data from multiple sources, recent advancements in a variety of analytical tools, and ongoing algorithmic advancements. The effects that machine learning technologies have had on drug design and discovery, preformulation, and formulation in the past, now, and in the future are summarized in this review. Artificial neural networks are emphasized due to their capacity to model the nonlinear relationships that are frequently encountered in pharmaceutical research. This section discusses the machine learning techniques that are frequently utilized in pharmaceutical sciences. The common pharma needs, industrial and regulatory insights, and AI and machine learning technologies are reviewed. Past customary possibilities of carrying out advanced advances utilizing AI in the improvement of more productive, quick, and prudent arrangements in drug sciences are likewise examined [1].
Furthermore, there are two types of machine learning models: models with and without parameters. Parametric models sum up information with a bunch of steady number of boundaries (no matter what the quantity of preparing models), while nonparametric models are subject to the quantity of boundaries and consequently on the quantity of preparing models. The common parametric and nonparametric machine learning techniques utilized in various drug research and development studies are outlined in Table TableII. Keep in mind that each of these machine learning methods may have additional subtypes, so comparing these models as a whole may be unfair. For instance, although some machine learning techniques may necessitate large datasets, there is typically no optimal dataset size. For more information, the reader is encouraged to consult the cited sources. In addition, no machine learning approach is generally regarded as superior to others, and each issue (such as regression or classification) should be addressed separately.
Rosalyn Yalow, a medical physicist who lived from 1921 to 2011, was the first American woman to win the Nobel Prize in Physiology or Medicine for her work on the radioimmunoassay, along with Andrew Schally and Roger Guillemin. She began her career as a secretary, progressed to teaching assistant, and eventually worked in the radioisotope laboratory at the Bronx VA Hospital, where she developed the radioimmunoassay for precise hormone measurement. She was under the impression that graduate schools would not fund women. She was inducted into the National Women's Hall of Fame and honored with the National Medal of Science. Although she did not advocate for recognizing women in the sciences because she believed men and women ought to be treated equally, many admire her for her significant contributions.
It would be naive to believe that any of the life sciences fields could advance or even survive without the use of computational modeling, given the rapid expansion of computational power and the increasing availability of high performance computing systems. In addition, the application of computational methods is essential, extensive, and widespread in one of the most dynamic and interdisciplinary fields of science pharmacy that integrates fundamental principles of physical and organic chemistry, physics, engineering, biochemistry, biology, and medicine. However, even among scientists who use molecular modeling on a daily basis, the progressing narrow specialization reflects the interdisciplinarity of pharmaceutical sciences and their widespread application of computational methods. As a result, one of the goals of this review was to compile and present the most recent developments and applications in a very specific subfield of molecular modeling techniques: periodic DFT (density functional theory) calculations used in pharmaceutical sciences.
These days, an elevated degree of medical care is one of the essential guidelines for the residents in a cutting edge society. A prerequisite for such a standard is a sufficient supply of medical products, particularly drugs, as well as their rational administration. The pharmaceutical industry and pharmacist systems that are associated with drug production and administration in the majority of nations necessitate the collaboration of specialists in both fields [2-5].
In conclusion, to treat chronic conditions like diabetes, hypertension, and others, and severe epidemics, such as COVID-19 in 2019, the pharmaceutical industry and pharmacist system must urgently develop sustainably. It is generally perceived that training is the essential way to deal with ensure the economical improvement of a discipline. Because education research has the potential to support the rational design of curriculum, enhance evaluation systems, and update the study area for students, it is of great significance.
None.
There are no conflicts of interest by author.
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
